Glimepiride 1mg + Metformin 1000mg Tablet in PCD pharma franchise in Hyderabad

Glimepiride 1mg + Metformin 1000mg Tablet in pharmaceutical manufacturing company in Mumbai

Glimepiride 1mg + Metformin 1000mg Tablet in antidiabetic pharma franchise in Pune

Glimepiride 1mg + Metformin 1000mg Tablet in pharma suppliers in Delhi

Glimepiride 1mg + Metformin 1000mg Tablet in pharma export companies in Kolkata
Glimepiride 1mg + Metformin 1000mg Tablet in pharma franchise opportunities in Bengaluru

Home/Products /glimepiride-i-point-p-point-1mg-metformin-tablets

Gimtype M1 Forte Tablet

Composition : Glimepiride I.P. 1mg + Metformin (S.R.) I.P. 1000mg Bi-Layered Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*15

Price : ₹99/-

Metfoam G1 Forte Tablet is a fixed-dose bi-layered formulation combining Glimepiride 1mg and Metformin 1000mg (Sustained Release). This dual-action oral antidiabetic medication supports comprehensive glycemic control in patients with type 2 diabetes. Glimepiride stimulates insulin release from pancreatic β-cells, while Metformin improves peripheral glucose uptake and reduces hepatic glucose production. The sustained-release mechanism of Metformin ensures prolonged blood sugar control with reduced gastrointestinal disturbances.

Read More

About the Product

Metfoam G1 Forte Tablet is a fixed-dose bi-layered formulation combining Glimepiride 1mg and Metformin 1000mg (Sustained Release). This dual-action oral antidiabetic medication supports comprehensive glycemic control in patients with type 2 diabetes. Glimepiride stimulates insulin release from pancreatic β-cells, while Metformin improves peripheral glucose uptake and reduces hepatic glucose production. The sustained-release mechanism of Metformin ensures prolonged blood sugar control with reduced gastrointestinal disturbances.

May cause hypoglycemia, nausea, stomach upset, dizziness, or mild weight gain. In rare cases, Metformin may cause lactic acidosis, especially in patients with kidney issues.

Indicated for the effective management of type 2 diabetes mellitus in adults, particularly in patients who require both enhanced insulin release and improved insulin sensitivity to maintain optimal glycemic levels.

Should be taken with meals to minimize gastrointestinal side effects. Regular monitoring of blood glucose and renal function is essential. Not suitable for patients with type 1 diabetes or diabetic ketoacidosis.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation